Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
Open Access
- 27 December 2019
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 14 (1) , 1-10
Abstract
Background: The effectiveness of proton beam therapy (PBT) as initial treatment for patients with unresectable intrahepatic cholangiocarcinoma (ICC) is unclear, particularly as related to ICC histological subtypes. We performed this study to address this gap in knowledge. Methods: Thirty-seven patients with unresectable ICC who underwent PBT as their initial treatment were evaluated. Twenty-seven patients had Child-Pugh class A liver function, 11 exhibited jaundice, and 10 had multiple tumors. Nineteen, 7, and 11 tumors were classified as mass forming (MF), periductal infiltrating (PI), and intraductal growth (IG) types, respectively, based on gross appearance in imaging studies. Patients were classified into the curative group (n = 25) and palliative group (n = 12) depending on whether the planning target volume covered all the macroscopic tumors. Results: The 1- and 2-year overall survival rates were 60.3, and 41.4%, respectively; the median survival time (MST) was 15 months for all patients. The MSTs for curative and palliative groups were 25 and 7 months, respectively. Curative treatment and adjuvant chemotherapy significantly improved overall survival, while the presence of periductal infiltrating type tumors was a negative prognostic factor. In the curative group, the 1- and 2-year local control rates were 100 and 71.5%, respectively, while the 1-, and 2-year progression-free survival rates were 58.5, and 37.6%, respectively. No severe acute toxicities were observed. Three patients experienced grade 3 biliary tract infection, although it was unclear whether this was radiotherapy-related. Conclusion: PBT may yield to improve survival and local tumor control among patients with unresectable ICC.Keywords
This publication has 32 references indexed in Scilit:
- Proton Beam Therapy for Hepatocellular Carcinoma Located Adjacent to the Alimentary TractInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational StudyGut and Liver, 2009
- Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyBritish Journal of Cancer, 2008
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Clinical Oncology, 2008
- Cholangiocarcinoma: A compact review of the literatureWorld Journal of Gastroenterology, 2008
- What prognostic factors are important for resected intrahepatic cholangiocarcinoma?Journal of Gastroenterology and Hepatology, 2007
- Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombusCancer, 2005
- A new staging system for mass-forming intrahepatic cholangiocarcinomaCancer, 2001
- Lymphatic spreading pattern of intrahepatic cholangiocarcinomaSurgery, 2001